Aviva shares: why three banks think the FTSE 100 insurer is still too cheap

Aviva reported strong 2025 results, but the performance did little to close a persistent valuation gap; the shares continue to trade at a meaningful discount to peers despite consistent delivery. Analysts view Aviva as a compelling case in the European financial sector, yet the ongoing discount indicates limited near-term scope for a broad re-rating.

Analysis

Aviva’s business mix (UK life liabilities + general insurance float + asset management) creates asymmetric exposure to the interest-rate and spread environment: sustained higher real yields materially rebuild capital generation through reinvestment and reserve unlocking, while a rapid fall in yields re-imposes mark-to-market and LDI frictions. The near-term re-rating mechanism is therefore not earnings beats but demonstrable, repeatable capital returns (dividends + buybacks) and visible shrinkage of estate risk — investors will treat repeatable cash returns as the credible path to multiple expansion.

Second-order winners from that path include reinsurers (who pick up ceded volatility), asset managers handling insurer assets (higher AUM margins on fixed income strategies) and pension consolidators that may compete for orphan liabilities if Aviva accelerates sell-downs. Key near-term tail risks are gilt/LDI volatility, a large nat-cat sequence, or a regulatory push that raises capital buffers — any of these can wipe out a quarter or more of surplus capital within weeks and push re-rating out by 6–18 months.

Given the likely slow grind to recognition, the highest-expected-return approach is event-driven exposure sized to capital-return cadence rather than a pure value trap bet. Watch solvency metrics, announced buyback cadence and liability hedging ratios as triggers; if buybacks are executed at scale and persistency trends improve, expect a rapid re-rating within 3–12 months as domestic asset allocators rotate away from bonds back into insurer equity.

Key Decisions for Investors

• Long Aviva (AV.L) equity, 6–12 month horizon: position size 2–4% portfolio, target +30% upside if next two quarters show sequential buybacks/dividend hikes, stop-loss at -15% to limit capital tie-up — reward:risk ≈ 2:1–3:1.
• Pair trade: long AV.L / short Prudential (PRU.L) or Legal & General (LGEN.L), equal notional, 6–12 months — removes market beta and isolates insurer-specific re-rating; use if you expect UK capital returns to outpace peers by 200–400bps of ROE improvement.
• Buy AV.L 12-month call spread (buy ATM, sell 25% OTM) to cap cost while capturing upside if catalysts hit; position size <2% and hedge with a 6–12 month 10–15% OTM put to protect against a gilt-driven drawdown.
• Event hedge: if Aviva announces a sizable buyback, add incremental long or remove pair short; if solvency ratio falls >5 percentage points or there’s a material nat-cat loss, unwind longs and switch to 3–6 month protection (puts) — treat re-rating as binary on execution of capital returns.